Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The organophosphorus antidotes, so-called oximes, are able to restore the enzymatic function of acetylcholinesterase (AChE) or butyrylcholinesterase (BChE) via cleavage of organophosphate from the active site of the phosphylated enzyme. In this work, the charged pyridinium oximes containing thiocarboxamide moiety were designed, prepared and tested. Their stability and p K a properties were found to be analogous to parent carboxamides (K027, K048 and K203). The inhibitory ability of thiocarboxamides was found in low µM levels for AChE and high µM levels for BChE. Their reactivation properties were screened on human recombinant AChE and BChE inhibited by nerve agent surrogates and paraoxon. One thiocarboxamide was able to effectively restore function of NEMP- and NEDPA-AChE, whereas two thiocarboxamides were able to reactivate BChE inhibited by all tested organophosphates. These results were confirmed by reactivation kinetics, where thiocarboxamides were proved to be effective, but less potent reactivators if compared to carboxamides.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: not found
          • Article: not found

          A new and rapid colorimetric determination of acetylcholinesterase activity.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.

            Since the September 11, 2001, terrorist attacks in the United States, the specter of a chemical threat against civilian populations has renewed research interest in chemical warfare agents, their mechanisms of action, and treatments that reverse their effects. In this Account, we focus specifically on organophosphorus nerve agents (OPNAs). Although some OPNAs are used as pest control, the most toxic chemicals in this class are used as chemical warfare agents in armed conflicts. The acute toxicity of OPNAs results from the irreversible inhibition of acetylcholinesterase (AChE, EC 3.1.1.7) via the formation of a covalent P-O bond at the serine hydroxyl group in the enzyme active site. AChE breaks down the neurotransmitter acetylcholine at neuronal synapses and neuromuscular junctions. The irreversible inhibition of AChE causes the neurotransmitter to accumulate in the synaptic cleft, leading to overstimulation of cholinergic receptors, seizures, respiratory arrest, and death. The current treatment for OPNA poisoning combines an antimuscarinic drug (e.g., atropine), an anticonvulsant drug (e.g., diazepam), and an AChE reactivator of the pyridinium aldoxime family (pralidoxime, trimedoxime, obidoxime, HI-6, HLö-7). Because of their high nucleophilicity, oximes can displace the phosphyl group from the catalytic serine, thus restoring the enzyme's catalytic activity. During 50 years of research in the reactivator field, researchers have synthesized and tested numerous structural modifications of monopyridinium oximes and bispyridinium oximes. In the past decade, medicinal chemists have focused their research on the more efficient bispyridinium reactivators, but all known reactivators have several drawbacks. First, due to their permanent positive charge, they do not cross the blood-brain barrier (BBB) efficiently and do not readily reactivate AChE in the central nervous system. Second, no single oxime is efficient against a wide variety of OPNAs. Third, oximes cannot reactivate "aged" AChE. This Account summarizes recent strategies for the development of AChE reactivators capable of crossing the BBB. The use of nanoparticulate transport and inhibition of P-glycoprotein efflux pumps improves BBB transport of these AChE reactivators. Chemical modifications that increased the lipophilicity of the pyridinium aldoximes, the addition of a fluorine atom and the replacement of a pyridyl ring with a dihydropyridyl moiety, enhances BBB permeability. The glycosylation of pyridine aldoximes facilitates increased BBB penetration via the GLUT-1 transport system. The development of novel uncharged reactivators that can move efficiently across the BBB represents one of the most promising of these new strategies.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Organophosphate poisoning

                Bookmark

                Author and article information

                Journal
                J Enzyme Inhib Med Chem
                J Enzyme Inhib Med Chem
                Journal of Enzyme Inhibition and Medicinal Chemistry
                Taylor & Francis
                1475-6366
                1475-6374
                23 February 2022
                2022
                23 February 2022
                : 37
                : 1
                : 760-767
                Affiliations
                [a ]Faculty of Science, Department of Chemistry, University of Hradec Kralove , Hradec Kralove, Czech Republic
                [b ]Biomedical Research Centre, University Hospital in Hradec Kralove , Hradec Kralove, Czech Republic
                Author notes

                Supplemental data for this article can be accessed here .

                CONTACT David Malinak david.malinak@uhk.cz; Kamil Musilek kamil.musilek@ 123456gmail.com Faculty of Science, Department of Chemistry, University of Hradec Kralove , Hradec Kralove, 500 03, Czech Republic
                Author information
                https://orcid.org/0000-0003-3382-3997
                https://orcid.org/0000-0002-0665-0667
                https://orcid.org/0000-0003-1108-3924
                https://orcid.org/0000-0001-7754-4231
                https://orcid.org/0000-0002-7857-7411
                https://orcid.org/0000-0003-4984-9155
                https://orcid.org/0000-0001-9698-4478
                https://orcid.org/0000-0002-7504-4062
                Article
                2041628
                10.1080/14756366.2022.2041628
                8881075
                35193448
                514b00e5-b50e-4d58-8a31-b7d7b6de5983
                © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Figures: 7, Tables: 2, Pages: 8, Words: 5220
                Categories
                Research Article
                Research Paper

                Pharmaceutical chemistry
                cholinesterase,organophosphate,oxime,inhibition,reactivation
                Pharmaceutical chemistry
                cholinesterase, organophosphate, oxime, inhibition, reactivation

                Comments

                Comment on this article